This compound is primarily used in organic synthesis, particularly in Suzuki-Miyaura cross-coupling reactions, where it acts as a boronic acid reagent. Its structure, featuring a trifluoromethyl group and an ethylpiperazine moiety, makes it valuable for creating complex molecules, especially in pharmaceutical research. The trifluoromethyl group enhances the lipophilicity and metabolic stability of the resulting compounds, which is beneficial in drug development. Additionally, the ethylpiperazine group can contribute to binding interactions with biological targets, making it useful in designing molecules for therapeutic applications. It is often employed in the synthesis of potential drug candidates targeting various diseases, including central nervous system disorders and cancer.